HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

DMP 696

a CRF(1) receptor antagonist; structure in first source

Also Known As:

4-(1,3-dimethoxy-2-propylamino)-2,7-dimethyl-8-(2,4-dichlorophenyl)(1,5-a)pyrazolo-1,3,5-triazine; DMP-696; DMP696

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Pyrazoles: 61
      - DMP 696: 2
  - Triazines: 306
    - DMP 696: 2

Experts

1.	Dahlhoff, Maik: 1 article (02/2012)
2.	Deussing, Jan M: 1 article (02/2012)
3.	Eder, Matthias: 1 article (02/2012)
4.	Henes, Kathrin: 1 article (02/2012)
5.	Holsboer, Florian: 1 article (02/2012)
6.	Moosmang, Sven: 1 article (02/2012)
7.	Thoeringer, Christoph K: 1 article (02/2012)
8.	Wotjak, Carsten T: 1 article (02/2012)
9.	Wurst, Wolfgang: 1 article (02/2012)
10.	Gilligan, Paul J: 1 article (12/2002)

Related Diseases

1.	Shock 02/01/2012 - "This could be achieved, if DMP696 was administered for 1 week starting as late as 24 h after foot shock. "
2.	Ataxia (Dyssynergia) 12/01/2002 - "The CRF(1) receptor antagonist DMP696 produces anxiolytic effects and inhibits the stress-induced hypothalamic-pituitary-adrenal axis activation without sedation or ataxia in rats."

Related Drugs and Biologics

1.	Anti-Anxiety Agents (Anxiolytics)